nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antigen/antibody content of circulating immune complexes in HIV-infected patients
|
Stanojevic, M |
|
1996 |
50 |
10 |
p. 488-493 6 p. |
artikel |
2 |
Author index
|
|
|
1996 |
50 |
10 |
p. 515- 1 p. |
artikel |
3 |
Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results
|
Hendel, H |
|
1996 |
50 |
10 |
p. 480-487 8 p. |
artikel |
4 |
Effect of the 5-HT3 receptor antagonist ondansetron on plasma AVP secretion: a study in cancer patients
|
Barreca, T |
|
1996 |
50 |
10 |
p. 512-514 3 p. |
artikel |
5 |
Isolation and virological characterization of HIV-1 in Cuba. Relationship with the clinical status of the patients
|
Lobaina, L |
|
1996 |
50 |
10 |
p. 501-504 4 p. |
artikel |
6 |
Lymphangiographic study of pelvic adenopathy regression in a phase II trial of methyl-hydroxy-ellipticine in HIV1-AIDS complex
|
Mathé, G |
|
1996 |
50 |
10 |
p. 510-511 2 p. |
artikel |
7 |
Lymphoproliferative response to synthetic V3 loop P18 peptide and HIV-1 envelope glycoprotein among individuals immunized with gp160 candidate vaccines
|
Moukrim, Z |
|
1996 |
50 |
10 |
p. 494-499 6 p. |
artikel |
8 |
Purine metabolism in HIV-1 virus-infected T lymphocyte population
|
Carlucci, F |
|
1996 |
50 |
10 |
p. 505-509 5 p. |
artikel |
9 |
Surgical indications for HIV-infected patients
|
Eriguchi, M |
|
1996 |
50 |
10 |
p. 500- 1 p. |
artikel |
10 |
Will killing the last HIV1 particle cure AIDS patients? II: Second part. Decrease of viral load and of T-suppressor cells, and increase of the cytotoxic cells, without effect on CD4, after the use of 10 virostatics applied in 3 or 4 drug combinations of different sequences. The time for CD4 immunotherapy?
|
Mathé, G |
|
1996 |
50 |
10 |
p. 473-479 7 p. |
artikel |